237 related articles for article (PubMed ID: 37516880)
1. Metformin attenuates chronic lung allograft dysfunction: evidence in rat models.
Tian D; Zheng X; Tang H; Huang H; Wang J; Xu L; Li C; Yan H; Yu R; Nan J; Liu M; Guo X; Jian S; Wang T; Deng S; Pu Q; Liu L
Respir Res; 2023 Jul; 24(1):192. PubMed ID: 37516880
[TBL] [Abstract][Full Text] [Related]
2. The activity of nintedanib in an animal model of allogenic left lung transplantation resembling aspects of allograft rejection.
von Suesskind-Schwendi M; Boxhammer E; Hirt SW; Schreml S; Schmid C; Wollin L; Lehle K
Exp Lung Res; 2017; 43(6-7):259-270. PubMed ID: 29035589
[TBL] [Abstract][Full Text] [Related]
3. Anti-oxidative effect of the tyrosine kinase inhibitor nintedanib: a potential therapy for chronic lung allograft dysfunction?
Boxhammer E; Lehle K; Schmid C; von Suesskind-Schwendi M
Exp Lung Res; 2020; 46(5):128-145. PubMed ID: 32169022
[No Abstract] [Full Text] [Related]
4. Adaptive and innate immune responses in a rat orthotopic lung transplant model of chronic lung allograft dysfunction.
Evers A; Atanasova S; Fuchs-Moll G; Petri K; Wilker S; Zakrzewicz A; Hirschburger M; Padberg W; Grau V
Transpl Int; 2015 Jan; 28(1):95-107. PubMed ID: 25179205
[TBL] [Abstract][Full Text] [Related]
5. A novel model for dissecting roles of IL-17 in lung transplantation.
Chen R; Liang F; Chen Q; Xu J; Ding Y
J Thorac Dis; 2018 Jun; 10(6):3298-3307. PubMed ID: 30069326
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
[TBL] [Abstract][Full Text] [Related]
7. Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+ T cells, selectively inhibited by the immune check-point HLA-G.
Brugière O; Mouren D; Trichereau J; Vallée A; Kuzniak I; Hirschi S; Renaud-Picard B; Reynaud-Gaubert M; Nieves A; Bunel V; Messika J; Demant X; Macey J; Le Pavec J; Dauriat G; Saint-Raymond C; Falque L; Mornex JF; Tissot A; Foureau A; Borgne Krams AL; Bousseau V; Magnan A; Picard C; Roux A; Carosella E; LeMaoult J; Rouas-Freiss N;
J Heart Lung Transplant; 2022 May; 41(5):626-640. PubMed ID: 35181243
[TBL] [Abstract][Full Text] [Related]
8. Pre-transplant donor-specific transfusions induce allograft rejection and IL-2 gene expression in the WKY-->F344 functional tolerance model of rat lung transplantation.
Okada Y; Zuo XJ; Marchevsky AM; Toyoda M; Pass JA; Matloff JM; Jordan SC
Transpl Immunol; 1998 Sep; 6(3):137-46. PubMed ID: 9848219
[TBL] [Abstract][Full Text] [Related]
9. Lung Density Analysis Using Quantitative Chest CT for Early Prediction of Chronic Lung Allograft Dysfunction.
Horie M; Levy L; Houbois C; Salazar P; Saito T; Pakkal M; OʼBrien C; Sajja S; Brock K; Yasufuku K; Keshavjee S; Paul N; Martinu T
Transplantation; 2019 Dec; 103(12):2645-2653. PubMed ID: 31343572
[TBL] [Abstract][Full Text] [Related]
10. Validation of a post-transplant chronic lung allograft dysfunction classification system.
Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
[TBL] [Abstract][Full Text] [Related]
11. Genetic effect of ischemia-reperfusion injury upon primary graft dysfunction and chronic lung allograft dysfunction in lung transplantation: evidence based on transcriptome data.
Zheng XY; Huang H; Wei ZT; Yan HJ; Wang XW; Xu L; Li CH; Tang HT; Wang JJ; Yu ZW; Tian D
Transpl Immunol; 2022 Apr; 71():101556. PubMed ID: 35202801
[TBL] [Abstract][Full Text] [Related]
12. A novel cardioprotective agent in cardiac transplantation: metformin activation of AMP-activated protein kinase decreases acute ischemia-reperfusion injury and chronic rejection.
Chin JT; Troke JJ; Kimura N; Itoh S; Wang X; Palmer OP; Robbins RC; Fischbein MP
Yale J Biol Med; 2011 Dec; 84(4):423-32. PubMed ID: 22180679
[TBL] [Abstract][Full Text] [Related]
13. Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts.
Pison C; Tissot A; Bernasconi E; Royer PJ; Roux A; Koutsokera A; Coiffard B; Renaud-Picard B; Le Pavec J; Mordant P; Demant X; Villeneuve T; Mornex JF; Nemska S; Frossard N; Brugière O; Siroux V; Marsland BJ; Foureau A; Botturi K; Durand E; Pellet J; Danger R; Auffray C; Brouard S; Nicod L; Magnan A;
Front Med (Lausanne); 2023; 10():1126697. PubMed ID: 36968829
[TBL] [Abstract][Full Text] [Related]
14. Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction.
Rousselière A; Delbos L; Foureau A; Reynaud-Gaubert M; Roux A; Demant X; Le Pavec J; Kessler R; Mornex JF; Messika J; Falque L; Le Borgne A; Boussaud V; Tissot A; Hombourger S; Bressollette-Bodin C; Charreau B
Front Immunol; 2023; 14():1143875. PubMed ID: 37187736
[TBL] [Abstract][Full Text] [Related]
15. Activation of Humoral Immunity during the Pathogenesis of Experimental Chronic Lung Allograft Dysfunction.
Reichert M; Atanasova S; Petri K; Kampschulte M; Kojonazarov B; Fuchs-Moll G; Krombach GA; Padberg W; Grau V
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897686
[TBL] [Abstract][Full Text] [Related]
16. Oxygenated Hemoglobin Predicts Outcome in Patients with Chronic Lung Allograft Dysfunction.
Kahnert K; Trudzinski FC; Berger C; Munker D; Milger K; Irlbeck M; Tomasi R; Schneider C; Michel S; Ghiani A; Herth FJF; Behr J; Jörres RA; Kneidinger N
Respiration; 2022; 101(7):638-645. PubMed ID: 35354156
[TBL] [Abstract][Full Text] [Related]
17. Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
Stadlbauer TH; Schaub M; Magee CC; Kupiec-Weglinski JW; Sayegh MH
J Heart Lung Transplant; 2000 Jun; 19(6):566-75. PubMed ID: 10867337
[TBL] [Abstract][Full Text] [Related]
18. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
Zhang CX; Pan SN; Meng RS; Peng CQ; Xiong ZJ; Chen BL; Chen GQ; Yao FJ; Chen YL; Ma YD; Dong YG
Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698
[TBL] [Abstract][Full Text] [Related]
19. Impact of gram negative bacteria airway recolonization on the occurrence of chronic lung allograft dysfunction after lung transplantation in a population of cystic fibrosis patients.
Orfanos S; Gomez C; Baron S; Akkisetty R; Dufeu N; Coltey B; Thomas PA; Rolain JM; Reynaud-Gaubert M
BMC Microbiol; 2018 Aug; 18(1):88. PubMed ID: 30126365
[TBL] [Abstract][Full Text] [Related]
20. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
